About Somerset Therapeutics
Somerset Therapeutics was founded in 2015 in Somerset, United States, as a manufacturer in the energy and telecommunications sectors. Manufacturing facilities are established and invested in to produce cable technology, materials, and related products. Operations cover the full process from production to distribution, with products marketed domestically and internationally. Customer needs are addressed through these activities, supporting industry standards.
- Headquarter Somerset, United States
- Founders Ilango Subramanian, Veerappan Subramanian
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Endo International
(Apr 25, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Somerset Therapeutics
Detailed funding history for Somerset Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Somerset Therapeutics
Somerset Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Endo International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global pharmaceutical company manufacturing branded, generic formulations, and OTC medicines
|
Locked | Locked | Locked |
Investor details for Somerset Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Somerset Therapeutics
Investment portfolio details for Somerset Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Somerset Therapeutics
Detailed financials for Somerset Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Somerset Therapeutics Comparisons
Peer comparison for Somerset Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Somerset Therapeutics
Detailed competitors of Somerset Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Somerset Therapeutics
Complete news archive for Somerset Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Somerset Therapeutics
Somerset Therapeutics was founded in 2015.
Somerset Therapeutics is headquartered in Somerset, United States.
Veerappan Subramanian is the current CEO of Somerset Therapeutics. They have also founded this company.
Somerset Therapeutics was founded in 2015 in Somerset, United States, as a manufacturer in the energy and telecommunications sectors. Manufacturing facilities are established and invested in to produce cable technology, materials, and related products. Operations cover the full process from production to distribution, with products marketed domestically and internationally. Customer needs are addressed through these activities, supporting industry standards.
Somerset Therapeutics has 1 investor. Key investors include Endo International.